{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T04:59:21Z","timestamp":1770958761828,"version":"3.50.1"},"reference-count":57,"publisher":"Wiley","issue":"21","license":[{"start":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T00:00:00Z","timestamp":1334620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2012,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND:<\/jats:title><jats:p>Inhibition of the hedgehog signaling pathway (HHSP) for the treatment of locally advanced basal cell carcinoma (BCC) and metastatic BCC (mBCC) has produced promising results. Typically, mBCC is not taken into consideration during the workup of a patient with multifocal metastatic disease who has a history of BCC. The objective of the current review, in which the authors evaluated the time from the first BCC diagnosis to metastasis, location of disease, and radiographic features, was to contribute to the general knowledge and awareness among providers, patients, and support groups about mBCC and to provide an outlook for the future of treatments for mBCC. A literature review on mBCC and a review of records from patients with mBCC who presented to Virginia G. Piper Cancer Center Clinical Trials (an oncology clinical trials center) were conducted. The clinical and radiographic findings of 22 patients with mBCC who were evaluated at that center from the initiation of smoothened (SMO) antagonist trials were analyzed along with a review of BCC epidemiology and pathogenesis, the HHSP, and current and future treatments for this rare presentation of the most common malignancy. The results indicated that, in the last 5 years, there has been a plethora of new agents targeting SMO, a key component of the HHSP that, for the majority of patients with mBCC, may be a good match for targeting tumor genetic vulnerability. Like with other targeted therapy for uncommon malignancies, such as chronic myelogenous leukemia and gastrointestinal stromal tumors, the authors anticipate that there will be clinical development of next\u2010generation HHSP inhibitors to combat mBCCs that are nonresponsive to or progress on current SMO antagonists. Cancer 2012. \u00a9 2012 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.27532","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T12:43:16Z","timestamp":1334666596000},"page":"5310-5319","source":"Crossref","is-referenced-by-count":30,"title":["Metastatic basal cell carcinoma in the era of hedgehog signaling pathway inhibitors"],"prefix":"10.1002","volume":"118","author":[{"given":"Glen J.","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald L.","family":"Korn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,4,17]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(08)81509-5"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1177\/014556130007900710"},{"key":"e_1_2_4_4_2","unstructured":"American Cancer Society Cancer. Facts and Figures 2011. Available at:http:\/\/www.cancer.org\/Research\/CancerFactsFigures\/CancerFactsFigures\/cancer\u2010facts\u2010figures\u20102011. Accessed on July 31 2011."},{"key":"e_1_2_4_5_2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5070\/D373C4H22M","article-title":"Basal cell carcinoma does metastasize [serial online]","volume":"14","author":"Ozgediz D","year":"2008","journal-title":"Dermatol Online J."},{"key":"e_1_2_4_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46307"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2008.03.002"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70056-N"},{"key":"e_1_2_4_9_2","first-page":"25","article-title":"Variations in clinical presentation of basal cell carcinoma","volume":"47","author":"Buljan M","year":"2008","journal-title":"Acta Clin Croat."},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(93)70165-P"},{"key":"e_1_2_4_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910530410"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.135.7.781"},{"key":"e_1_2_4_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-3-32"},{"key":"e_1_2_4_15_2","first-page":"259","article-title":"PTCH1 gene analysis in 25 Japanese patients with Gorlin syndrome [article in Japanese]","volume":"41","author":"Endo M","year":"2009","journal-title":"No To Hattatsu."},{"key":"e_1_2_4_16_2","first-page":"253","article-title":"Clinical manifestations in 25 Japanese patients with Gorlin syndrome [article in Japanese]","volume":"41","author":"Tanabe R","year":"2009","journal-title":"No To Hattatsu."},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.GIM.0000145045.17711.1C"},{"key":"e_1_2_4_18_2","doi-asserted-by":"publisher","DOI":"10.1177\/014556130408300115"},{"key":"e_1_2_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4725.2006.32110.x"},{"key":"e_1_2_4_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800512"},{"key":"e_1_2_4_21_2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D313V4J8VJ","article-title":"Metastatic basal cell carcinoma: a case report and literature review. How accurate is our incidence data [serial online]?","volume":"12","author":"Wadhera A","year":"2006","journal-title":"Dermatol Online J."},{"key":"e_1_2_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70108-E"},{"key":"e_1_2_4_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.01.004"},{"key":"e_1_2_4_24_2","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2011.23.2.213"},{"key":"e_1_2_4_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195107)4:4<866::AID-CNCR2820040424>3.0.CO;2-F"},{"key":"e_1_2_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)80334-5"},{"key":"e_1_2_4_27_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602852103"},{"key":"e_1_2_4_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-005-0027-1"},{"key":"e_1_2_4_29_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.9.1141"},{"key":"e_1_2_4_30_2","unstructured":"American Cancer Society. Skin Cancer: Basal and Squamous Cell. Available at:http:\/\/www.cancer.org\/cancer\/skincancer\u2010basalandsquamouscell\/detailedguide\/skin\u2010cancer\u2010basal\u2010and\u2010squamous\u2010cell\u2010staging. [Access date.]"},{"key":"e_1_2_4_31_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905360"},{"key":"e_1_2_4_32_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2574"},{"key":"e_1_2_4_33_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0365-05962011000200013"},{"key":"e_1_2_4_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.34"},{"key":"e_1_2_4_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/00039896.1962.10663251"},{"key":"e_1_2_4_36_2","first-page":"1164","article-title":"A congenital cyclopian\u2010type malformation in lambs induced by maternal ingestion of a range plant, Veratrum californicum","volume":"24","author":"Binns W","year":"1963","journal-title":"Am J Vet Res."},{"key":"e_1_2_4_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420010103"},{"key":"e_1_2_4_38_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1098020"},{"key":"e_1_2_4_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)00977-7"},{"key":"e_1_2_4_40_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5369.1603"},{"key":"e_1_2_4_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2503"},{"key":"e_1_2_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2009.03.007"},{"key":"e_1_2_4_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1969"},{"key":"e_1_2_4_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(90)90262-R"},{"key":"e_1_2_4_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19831101)52:9<1583::AID-CNCR2820520907>3.0.CO;2-G"},{"key":"e_1_2_4_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-1433.2004.03130.x"},{"key":"e_1_2_4_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/07357900600705474"},{"key":"e_1_2_4_48_2","unstructured":"National Institutes of Health. National clinical trials website. Available at:http:\/\/www.clinicaltrials.gov. Accessed December 16 2011."},{"key":"e_1_2_4_49_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-2745"},{"key":"e_1_2_4_50_2","doi-asserted-by":"crossref","unstructured":"SekulicA MigdenMR OroAE et al.A pivotal study evaluating efficacy and safety of the hedgehog pathway inhibitor (HPI) vismodegib (GDC\u20100449) in patients with locally advanced or metastatic basal cell carcinoma (BCC). Paper presented at: Seventh European Association of Dermato\u2010Oncology (EADO) Congress; June 20\u201023 2011; Nantes France. Abstract C014.","DOI":"10.1097\/01.cmr.0000399448.65869.b7"},{"key":"e_1_2_4_51_2","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.3062","article-title":"Phase I study of LDE225 in advanced solid tumors: updated analysis of safety, preliminary efficacy, and pharmacokinetic\u2010pharmacodynamic correlation [abstract]","volume":"29","author":"Tawbi HA","year":"2011","journal-title":"J Clin Oncol."},{"key":"e_1_2_4_52_2","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2010.504714"},{"key":"e_1_2_4_53_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0040232"},{"key":"e_1_2_4_54_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-4173"},{"key":"e_1_2_4_55_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI42874"},{"key":"e_1_2_4_56_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.066431"},{"key":"e_1_2_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.02.027"},{"key":"e_1_2_4_58_2","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2011.29.15_suppl.3014","article-title":"A phase I study of IPI\u2010926, a novel hedgehog pathway inhibitor, in patients (pts) with advanced or metastatic solid tumors [abstract]","volume":"29","author":"Rudin CM","year":"2011","journal-title":"J Clin Oncol."}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.27532","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.27532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T09:53:46Z","timestamp":1760262826000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.27532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,17]]},"references-count":57,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.1002\/cncr.27532"],"URL":"https:\/\/doi.org\/10.1002\/cncr.27532","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,17]]}}}